Browsing Tag
John Kraus
1 post
FDA grants Otsuka’s Sibeprenlimab breakthrough therapy designation in IgAN
In a significant development for the treatment of kidney disease, the U.S. Food and Drug Administration (FDA) has…
Business news, market intelligence, and global industry analysis.